Rohan Ameratunga

13PUBLICATIONS
69CO-AUTHORS
Poverty, inclusivity and wellbeingCheminformatics and quantitative structure-activity relationshipsInnate immunityAnimal protection (incl. pests and pathogens)Immunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Nov 21, 2025
Common Variable Immune Deficiency Disorders (CVID) in the Indigenous Māori of Aotearoa (New Zealand) Are Associated With a High Prevalence of Bronchiectasis and Complete IgA Deficiency.

Rohan Ameratunga, Catherine A Byrnes, Anthony Jordan

|Aug 11, 2023
Soluble wild-type ACE2 molecules inhibit newer SARS-CoV-2 variants and are a potential antiviral strategy to mitigate disease severity in COVID-19.

Rohan Ameratunga, Emily Mears, Euphemia Leung

|Oct 10, 2022
Critical role of diagnostic SARS-CoV-2 T cell assays for immunodeficient patients.

Rohan Ameratunga, See-Tarn Woon, Richard Steele

|Jun 13, 2022
SARS-CoV-2 the ASIA virus (Autoimmune/autoinflammatory Syndrome Induced by Adjuvants), the risk of infertility and vaccine hesitancy.

Rohan Ameratunga

|May 13, 2022
Droplet digital PCR for identifying copy number variations in patients with primary immunodeficiency disorders.

See-Tarn Woon, Julia Mayes, Alexander Quach

|May 05, 2022
Severe COVID-19 is a T cell immune dysregulatory disorder triggered by SARS-CoV-2.

Rohan Ameratunga, See-Tarn Woon, Richard Steele

Pageof 3

Frequent Collaborators

5 joint publications

Euphemia Leung

1 joint publications

S Ameratunga

1 joint publications

T Hills

1 joint publications

L Huang